Quality of life in patients with long-term mechanical heart support

Czech version

Authors: M. Šáchová ¹; M. Šenkyříková ^1,2; A. Pospíšilová ¹
Authors‘ workplace: Katedra ošetřovatelství, LF MU, Brno ¹; Interní kardiologická klinika LF MU a FN Brno ²
Published in: Kardiol Rev Int Med 2017, 19(4): 266-272

Overview

Introduction:
Long-term mechanical heart support is the last stage of chronic heart failure treatment. The aim of the research was to evaluate how to what extent long-term mechanical heart support influences patient life quality.

Methodology:
The data have been acquired through a quantitative research method using the World Health Organization WHOQOL-BREF standardised questionnaire.

Results:
The research involved 51 patients (46 men and 5 women). The average age was 54.29 years. Seventeen respondents live with the HeartMate II long-term mechanical heart support and 34 respondents with HeartMate III. The average period from implantation is 15.76 months. In the domain of physical health it was established that the scores for individual age groups are below the BREF norm (except for the age group over 70 years). In the domain of emotions it was established that the indicators were slightly below the BREF norm in 3 of the 5 age groups and slightly above the BREF norm in 2 of the 5 age groups. In the domain of social relationships it was found that the age group of 18–29 years did not reach the BREF norm. In the domain of the surrounding environment all age groups exceeded the BREF norm value.

Conclusion:
Patients evaluate the quality of life after the implantation of long-term mechanical heart support in a positive way. It is obvious that patients perceive implantation as a stage before transplantation and they expect further improvement of their life quality. This fact could have a positive effect on patients’ answers.

Key words:
quality of life – patient – long-term mechanical heart support – HeartMate II – HeartMate III – quantitative

Sources

1. Pirk J, Málek I. Transplantace srdce. Praha: Karolinum 2008 (1. vyd).

2. Thoratec corporation. Důležitá aktualizace bezpečnostních informací. Dodatek k Příručce pacienta k HeartMate II LVAS. 2014. Stone Drive, Pleasaton (USA): Thoratec Corporation 2014.

3. Thoratec corporation. Příručka pacienta 2012. Stone Drive, Pleasaton (USA): Thoratec Corporation 2012.

4. Dragomirecká E, Bartoňová J. WHOQOL-BREF, WHOQOL-100: World Health Organization Quality of Life Assessment: příručka pro uživatele české verze dotazníků kvality života Světové zdravotnické organizace. (1. vyd.) Praha: Psychiatrické centrum 2006.

5. Kolektiv autorů a konzultantů. Slovník cizích slov. (2. vyd.) Praha: Encyklopedický dům 1996.

6. Slováček L, Slováčková B, Jebavý L et al. Kvalita života nemocných – jeden z důležitých parametrů komplexního hodnocení léčby. Vojen Zdrav Listy 2004; 73(1): 6– 9.

7. Payne J. Kvalita života a zdraví. (1. vyd.) Praha: Triton 2005.

8. Provazník M. Život s mechanickým srdcem. Bakalářská práce. Hradec Králové: Univerzita Karlova, Lékařská fakulta, Ústav sociálního lékařství: 2011. Dostupné na: https://is.cuni.cz/webapps/zzp/detail/110700/ .

9. Freislebenová L. Kvalita života seniorů po operaci srdce 2012. Diplomová práce. Brno: Masarykova Univerzita, Lékařská fakulta 2012. Dostupné na: https://theses.cz/id/v2fatl?lang=en.

10. Allen JG, Weiss ES, Schaffer JM et al. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant 2010; 29(3): 278– 285. doi: 10.1016/ j.healun.2009.07.017.

11. Mirabel M, Luyt CE, Leprince P et al. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 2011; 39(5): 1029– 1035. doi:10.1097/ CCM.0b013e31820ead45.